DNA and RNA oxidative damage in hepatocellular carcinoma patients and mortality during the first year of liver transplantation

doi:10.4254/wjh.v14.i6.1182

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 6

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3424)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-2) series.

Item

Count

PDF

140

WORD

HTML

1291

Figures (1-2)

450

Tables (1-2)

262

Sum=2175

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

306

Download

943

Sum=1249

Jun 27, 2022 (publication date) through Dec 28, 2024

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Hepatol. Jun 27, 2022; 14(6): 1182-1189
Published online Jun 27, 2022. doi: 10.4254/wjh.v14.i6.1182

DNA and RNA oxidative damage in hepatocellular carcinoma patients and mortality during the first year of liver transplantation

Leonardo Lorente, Sergio T Rodriguez, Pablo Sanz, Agustín F González-Rivero, Antonia Pérez-Cejas, Javier Padilla, Dácil Díaz, Antonio González, María M Martín, Alejandro Jiménez, Purificación Cerro, Julián Portero, Manuel A Barrera

Leonardo Lorente, Department ofIntensive Care, Hospital Universitario de Canarias, La Laguna 38320, Tenerife, Spain

Sergio T Rodriguez, María M Martín, Intensive Care Unit, Hospital Universitario Nuestra Señora Candelaria, Santa Cruz de Tenerife 38010, Spain

Pablo Sanz, Javier Padilla, Manuel A Barrera, Department of Surgery, Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife 38010, Spain

Agustín F González-Rivero, Antonia Pérez-Cejas, Department of Laboratory, Hospital Universitario de Canarias, La Laguna 38320, Spain

Dácil Díaz, Antonio González, Department of Digestive, Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife 38010, Spain

Alejandro Jiménez, Research Unit, Hospital Universitario de Canarias, La Laguna 38320, Spain

Purificación Cerro, Transplant Unit, Hospital Universitario Nuestra Señora Candelaria, Santa Cruz de Tenerife 38010, Spain

Julián Portero, Department of Radiology, Hospital Universitario Nuestra Señora Candelaria, Santa Cruz de Tenerife 38010, Spain

Author contributions: Lorente L was responsible for conception, design and coordination of the study, made substantial contributions to acquisition of data and analysis and interpretation of data and drafted the manuscript; Rodriguez ST, Sanz P, Portero J, Díaz D, González A, Martín MM, Cerro P, Portero J and Barrera MA made substantial contributions to acquisition of data and provided useful suggestions; González-Rivero AF and Pérez-Cejas A participated in blood determination levels; Jiménez A made substantial contributions to analysis and interpretation of data; All authors critically read and approved the manuscript and agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Institutional review board statement: The Institutional Board of the Hospital Universitario Nuestra Señora de Candelaria (Santa Cruz de Tenerife, Spain) approved the study protocol.

Informed consent statement: All study participants or their legal guardian provided informed written consent about personal and medical data collection prior to study enrolment.

Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.

Data sharing statement: The datasets generated during the current study are available from the corresponding author on reasonable request.

Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

Corresponding author: Leonardo Lorente, MD, PhD, Attending Doctor, Medical Assistant, Department of Intensive Care, Hospital Universitario de Canarias, Ofra, s/n., La Laguna 38320, Tenerife, Spain. lorentemartin@msn.com

Received: January 14, 2022
Peer-review started: January 14, 2022
First decision: March 24, 2022
Revised: March 28, 2022
Accepted: May 22, 2022
Article in press: May 22, 2022
Published online: June 27, 2022
Processing time: 159 Days and 20.5 Hours

Core Tip

Core Tip: The potential use of DNA and RNA oxidative damage to predict prognosis of patients with hepatocellular carcinoma who underwent liver transplantation is unknown. In this retrospective study serum levels of the three oxidized guanine species before liver transplantation in 114 patients were measured. One-year survivor patients showed lower serum oxidized guanine specie levels than non-survivor patients (P = 0.01). These preliminary results could induce studies to clarify the potential role of oxidative damage in the prognosis of liver transplantation patients due to hepatocellular carcinoma and to explore the use of antioxidant agents to reduce oxidative stress in those patients.